Loading…

A statistically established reference value determined for the Vaxarray Coronavirus (CoV) seroassay to characterize vaccination and natural infection

Serological diagnostic tests are available that measure antibody levels against SARS-CoV-2 antigens. We utilized the Vaxarray Coronavirus (CoV) seroassay, which measures SARS-CoV-2 IgG antibodies against the full-length spike protein (FLS), receptor binding domain (RBD), and S2 extracellular domain...

Full description

Saved in:
Bibliographic Details
Published in:BMC infectious diseases 2024-11, Vol.24 (1), p.1308-11, Article 1308
Main Authors: Porras, Francisco Mimica, Pineda, Gabriel, Mangilog, Abigail, Hernandez, Keith, Sikorski, Cynthia, Lane, Michelle
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c457t-df80dc96955f09519b74beaf65021f66ab2ee90f7b1ed44f1b438ce8569e92713
container_end_page 11
container_issue 1
container_start_page 1308
container_title BMC infectious diseases
container_volume 24
creator Porras, Francisco Mimica
Pineda, Gabriel
Mangilog, Abigail
Hernandez, Keith
Sikorski, Cynthia
Lane, Michelle
description Serological diagnostic tests are available that measure antibody levels against SARS-CoV-2 antigens. We utilized the Vaxarray Coronavirus (CoV) seroassay, which measures SARS-CoV-2 IgG antibodies against the full-length spike protein (FLS), receptor binding domain (RBD), and S2 extracellular domain (ECD). Previous serological studies have used reference values that have not been validated and require many samples. Here, we show statistically established reference values determined using the upper tail of the Student t-distribution method. The target population was any personnel age 18 years and older working on a U.S. Navy ship, and vaccinated with Wuhan variant. The relative fluorescence mean (RFM) reference values for the full-length spike protein, RBD, and S2 ECD were 17,731, 13,990 and 9096, respectively. By using generalized non-parametric regression and reference values for the RBD spike protein and S2 ECD of SARS-CoV-2, this study was able to distinguish vaccine-mediated immune responses from natural infections. We provide the method and statistical code as a resource to determine future reference values for other serological assays.
doi_str_mv 10.1186/s12879-024-10117-5
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9586037f2a444564a69907ff97a492f8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A816301800</galeid><doaj_id>oai_doaj_org_article_9586037f2a444564a69907ff97a492f8</doaj_id><sourcerecordid>A816301800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-df80dc96955f09519b74beaf65021f66ab2ee90f7b1ed44f1b438ce8569e92713</originalsourceid><addsrcrecordid>eNqNks1u1DAUhSMEoqXwAiyQJTbtIsV2nNheVqMCI1WqxM9srRvnesajTFzspOrwHrwvnk6pOogFyiL29XeOlZNTFG8ZPWdMNR8S40rqknJRMsqYLOtnxTETkpW8qsTzJ-uj4lVKa0qZVFy_LI4qXQtVSXZc_LogaYTRp9Fb6Pstwbxte59W2JGIDiMOFskt9BOSDkeMGz_kIxciGVdIFnAHMcKWzEIMA9z6OCVyOguLM5IwBkgpn42B2BVEsFnuf-7crPVDvjUMBIaO5OUUoSd-cGh309fFCwd9wjcP75Pi-8fLb7PP5dX1p_ns4qq0opZj2TlFO6sbXdeO6prpVooWwTU15cw1DbQcUVMnW4adEI61olIWVd1o1Fyy6qSY7327AGtzE_0G4tYE8OZ-EOLSQMzJ9Gh0rRpaScdBCFE3AhqtqXROSxCaO5W9TvdeNzH8mHKMZuOTxb6HAcOUTJX_lpZaNjqj7_9C12GKQ_7STAnONRdPqSXk-3M2YcwR7kzNhWJNRZmiNFPn_6Dy0-HG2zCg83l-IDg7EGRmxLtxCVNKZv71y_-z14tDlu9ZG0NKuTqPeTJqdn01-76a3Fdz31dTZ9G7hySmdoPdo-RPQavfPWTjow</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3142292469</pqid></control><display><type>article</type><title>A statistically established reference value determined for the Vaxarray Coronavirus (CoV) seroassay to characterize vaccination and natural infection</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Porras, Francisco Mimica ; Pineda, Gabriel ; Mangilog, Abigail ; Hernandez, Keith ; Sikorski, Cynthia ; Lane, Michelle</creator><creatorcontrib>Porras, Francisco Mimica ; Pineda, Gabriel ; Mangilog, Abigail ; Hernandez, Keith ; Sikorski, Cynthia ; Lane, Michelle</creatorcontrib><description>Serological diagnostic tests are available that measure antibody levels against SARS-CoV-2 antigens. We utilized the Vaxarray Coronavirus (CoV) seroassay, which measures SARS-CoV-2 IgG antibodies against the full-length spike protein (FLS), receptor binding domain (RBD), and S2 extracellular domain (ECD). Previous serological studies have used reference values that have not been validated and require many samples. Here, we show statistically established reference values determined using the upper tail of the Student t-distribution method. The target population was any personnel age 18 years and older working on a U.S. Navy ship, and vaccinated with Wuhan variant. The relative fluorescence mean (RFM) reference values for the full-length spike protein, RBD, and S2 ECD were 17,731, 13,990 and 9096, respectively. By using generalized non-parametric regression and reference values for the RBD spike protein and S2 ECD of SARS-CoV-2, this study was able to distinguish vaccine-mediated immune responses from natural infections. We provide the method and statistical code as a resource to determine future reference values for other serological assays.</description><identifier>ISSN: 1471-2334</identifier><identifier>EISSN: 1471-2334</identifier><identifier>DOI: 10.1186/s12879-024-10117-5</identifier><identifier>PMID: 39548371</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adolescent ; Adult ; Age composition ; Amino acids ; Analysis ; Antibodies ; Antibodies, Viral - blood ; Antigens ; Chronology ; Coronaviruses ; COVID-19 ; COVID-19 - blood ; COVID-19 - diagnosis ; COVID-19 - immunology ; COVID-19 Serological Testing - methods ; COVID-19 Serological Testing - standards ; COVID-19 Vaccines - immunology ; Cutoff ; Female ; Humans ; Humidity ; Immune response ; Immunoglobulin G ; Immunoglobulin G - blood ; Infections ; Male ; Manufacturers ; Medical care ; Middle Aged ; Military Personnel ; Naval vessels ; Nucleocapsid protein ; Pandemics ; Probability distribution ; Proteins ; Reagents ; Reference value ; Reference Values ; SARS-CoV-2 ; SARS-CoV-2 - immunology ; Serodiagnosis ; Serology ; Severe acute respiratory syndrome coronavirus 2 ; Spike Glycoprotein, Coronavirus - immunology ; Spike protein ; Statistical analysis ; Student t- distribution ; Testing ; Utilization ; Vaccination ; Vaccines ; Vaxarray Coronavirus (CoV) seroassay ; Viral diseases ; Young Adult</subject><ispartof>BMC infectious diseases, 2024-11, Vol.24 (1), p.1308-11, Article 1308</ispartof><rights>2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c457t-df80dc96955f09519b74beaf65021f66ab2ee90f7b1ed44f1b438ce8569e92713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/3142292469?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,25733,27903,27904,36991,36992,38495,43874,44569</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39548371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Porras, Francisco Mimica</creatorcontrib><creatorcontrib>Pineda, Gabriel</creatorcontrib><creatorcontrib>Mangilog, Abigail</creatorcontrib><creatorcontrib>Hernandez, Keith</creatorcontrib><creatorcontrib>Sikorski, Cynthia</creatorcontrib><creatorcontrib>Lane, Michelle</creatorcontrib><title>A statistically established reference value determined for the Vaxarray Coronavirus (CoV) seroassay to characterize vaccination and natural infection</title><title>BMC infectious diseases</title><addtitle>BMC Infect Dis</addtitle><description>Serological diagnostic tests are available that measure antibody levels against SARS-CoV-2 antigens. We utilized the Vaxarray Coronavirus (CoV) seroassay, which measures SARS-CoV-2 IgG antibodies against the full-length spike protein (FLS), receptor binding domain (RBD), and S2 extracellular domain (ECD). Previous serological studies have used reference values that have not been validated and require many samples. Here, we show statistically established reference values determined using the upper tail of the Student t-distribution method. The target population was any personnel age 18 years and older working on a U.S. Navy ship, and vaccinated with Wuhan variant. The relative fluorescence mean (RFM) reference values for the full-length spike protein, RBD, and S2 ECD were 17,731, 13,990 and 9096, respectively. By using generalized non-parametric regression and reference values for the RBD spike protein and S2 ECD of SARS-CoV-2, this study was able to distinguish vaccine-mediated immune responses from natural infections. We provide the method and statistical code as a resource to determine future reference values for other serological assays.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age composition</subject><subject>Amino acids</subject><subject>Analysis</subject><subject>Antibodies</subject><subject>Antibodies, Viral - blood</subject><subject>Antigens</subject><subject>Chronology</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - blood</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 Serological Testing - methods</subject><subject>COVID-19 Serological Testing - standards</subject><subject>COVID-19 Vaccines - immunology</subject><subject>Cutoff</subject><subject>Female</subject><subject>Humans</subject><subject>Humidity</subject><subject>Immune response</subject><subject>Immunoglobulin G</subject><subject>Immunoglobulin G - blood</subject><subject>Infections</subject><subject>Male</subject><subject>Manufacturers</subject><subject>Medical care</subject><subject>Middle Aged</subject><subject>Military Personnel</subject><subject>Naval vessels</subject><subject>Nucleocapsid protein</subject><subject>Pandemics</subject><subject>Probability distribution</subject><subject>Proteins</subject><subject>Reagents</subject><subject>Reference value</subject><subject>Reference Values</subject><subject>SARS-CoV-2</subject><subject>SARS-CoV-2 - immunology</subject><subject>Serodiagnosis</subject><subject>Serology</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Spike Glycoprotein, Coronavirus - immunology</subject><subject>Spike protein</subject><subject>Statistical analysis</subject><subject>Student t- distribution</subject><subject>Testing</subject><subject>Utilization</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Vaxarray Coronavirus (CoV) seroassay</subject><subject>Viral diseases</subject><subject>Young Adult</subject><issn>1471-2334</issn><issn>1471-2334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNks1u1DAUhSMEoqXwAiyQJTbtIsV2nNheVqMCI1WqxM9srRvnesajTFzspOrwHrwvnk6pOogFyiL29XeOlZNTFG8ZPWdMNR8S40rqknJRMsqYLOtnxTETkpW8qsTzJ-uj4lVKa0qZVFy_LI4qXQtVSXZc_LogaYTRp9Fb6Pstwbxte59W2JGIDiMOFskt9BOSDkeMGz_kIxciGVdIFnAHMcKWzEIMA9z6OCVyOguLM5IwBkgpn42B2BVEsFnuf-7crPVDvjUMBIaO5OUUoSd-cGh309fFCwd9wjcP75Pi-8fLb7PP5dX1p_ns4qq0opZj2TlFO6sbXdeO6prpVooWwTU15cw1DbQcUVMnW4adEI61olIWVd1o1Fyy6qSY7327AGtzE_0G4tYE8OZ-EOLSQMzJ9Gh0rRpaScdBCFE3AhqtqXROSxCaO5W9TvdeNzH8mHKMZuOTxb6HAcOUTJX_lpZaNjqj7_9C12GKQ_7STAnONRdPqSXk-3M2YcwR7kzNhWJNRZmiNFPn_6Dy0-HG2zCg83l-IDg7EGRmxLtxCVNKZv71y_-z14tDlu9ZG0NKuTqPeTJqdn01-76a3Fdz31dTZ9G7hySmdoPdo-RPQavfPWTjow</recordid><startdate>20241115</startdate><enddate>20241115</enddate><creator>Porras, Francisco Mimica</creator><creator>Pineda, Gabriel</creator><creator>Mangilog, Abigail</creator><creator>Hernandez, Keith</creator><creator>Sikorski, Cynthia</creator><creator>Lane, Michelle</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20241115</creationdate><title>A statistically established reference value determined for the Vaxarray Coronavirus (CoV) seroassay to characterize vaccination and natural infection</title><author>Porras, Francisco Mimica ; Pineda, Gabriel ; Mangilog, Abigail ; Hernandez, Keith ; Sikorski, Cynthia ; Lane, Michelle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-df80dc96955f09519b74beaf65021f66ab2ee90f7b1ed44f1b438ce8569e92713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age composition</topic><topic>Amino acids</topic><topic>Analysis</topic><topic>Antibodies</topic><topic>Antibodies, Viral - blood</topic><topic>Antigens</topic><topic>Chronology</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - blood</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 Serological Testing - methods</topic><topic>COVID-19 Serological Testing - standards</topic><topic>COVID-19 Vaccines - immunology</topic><topic>Cutoff</topic><topic>Female</topic><topic>Humans</topic><topic>Humidity</topic><topic>Immune response</topic><topic>Immunoglobulin G</topic><topic>Immunoglobulin G - blood</topic><topic>Infections</topic><topic>Male</topic><topic>Manufacturers</topic><topic>Medical care</topic><topic>Middle Aged</topic><topic>Military Personnel</topic><topic>Naval vessels</topic><topic>Nucleocapsid protein</topic><topic>Pandemics</topic><topic>Probability distribution</topic><topic>Proteins</topic><topic>Reagents</topic><topic>Reference value</topic><topic>Reference Values</topic><topic>SARS-CoV-2</topic><topic>SARS-CoV-2 - immunology</topic><topic>Serodiagnosis</topic><topic>Serology</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Spike Glycoprotein, Coronavirus - immunology</topic><topic>Spike protein</topic><topic>Statistical analysis</topic><topic>Student t- distribution</topic><topic>Testing</topic><topic>Utilization</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Vaxarray Coronavirus (CoV) seroassay</topic><topic>Viral diseases</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Porras, Francisco Mimica</creatorcontrib><creatorcontrib>Pineda, Gabriel</creatorcontrib><creatorcontrib>Mangilog, Abigail</creatorcontrib><creatorcontrib>Hernandez, Keith</creatorcontrib><creatorcontrib>Sikorski, Cynthia</creatorcontrib><creatorcontrib>Lane, Michelle</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Directory of Open Access Journals</collection><jtitle>BMC infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Porras, Francisco Mimica</au><au>Pineda, Gabriel</au><au>Mangilog, Abigail</au><au>Hernandez, Keith</au><au>Sikorski, Cynthia</au><au>Lane, Michelle</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A statistically established reference value determined for the Vaxarray Coronavirus (CoV) seroassay to characterize vaccination and natural infection</atitle><jtitle>BMC infectious diseases</jtitle><addtitle>BMC Infect Dis</addtitle><date>2024-11-15</date><risdate>2024</risdate><volume>24</volume><issue>1</issue><spage>1308</spage><epage>11</epage><pages>1308-11</pages><artnum>1308</artnum><issn>1471-2334</issn><eissn>1471-2334</eissn><abstract>Serological diagnostic tests are available that measure antibody levels against SARS-CoV-2 antigens. We utilized the Vaxarray Coronavirus (CoV) seroassay, which measures SARS-CoV-2 IgG antibodies against the full-length spike protein (FLS), receptor binding domain (RBD), and S2 extracellular domain (ECD). Previous serological studies have used reference values that have not been validated and require many samples. Here, we show statistically established reference values determined using the upper tail of the Student t-distribution method. The target population was any personnel age 18 years and older working on a U.S. Navy ship, and vaccinated with Wuhan variant. The relative fluorescence mean (RFM) reference values for the full-length spike protein, RBD, and S2 ECD were 17,731, 13,990 and 9096, respectively. By using generalized non-parametric regression and reference values for the RBD spike protein and S2 ECD of SARS-CoV-2, this study was able to distinguish vaccine-mediated immune responses from natural infections. We provide the method and statistical code as a resource to determine future reference values for other serological assays.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>39548371</pmid><doi>10.1186/s12879-024-10117-5</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2334
ispartof BMC infectious diseases, 2024-11, Vol.24 (1), p.1308-11, Article 1308
issn 1471-2334
1471-2334
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_9586037f2a444564a69907ff97a492f8
source Publicly Available Content Database; PubMed Central; Coronavirus Research Database
subjects Adolescent
Adult
Age composition
Amino acids
Analysis
Antibodies
Antibodies, Viral - blood
Antigens
Chronology
Coronaviruses
COVID-19
COVID-19 - blood
COVID-19 - diagnosis
COVID-19 - immunology
COVID-19 Serological Testing - methods
COVID-19 Serological Testing - standards
COVID-19 Vaccines - immunology
Cutoff
Female
Humans
Humidity
Immune response
Immunoglobulin G
Immunoglobulin G - blood
Infections
Male
Manufacturers
Medical care
Middle Aged
Military Personnel
Naval vessels
Nucleocapsid protein
Pandemics
Probability distribution
Proteins
Reagents
Reference value
Reference Values
SARS-CoV-2
SARS-CoV-2 - immunology
Serodiagnosis
Serology
Severe acute respiratory syndrome coronavirus 2
Spike Glycoprotein, Coronavirus - immunology
Spike protein
Statistical analysis
Student t- distribution
Testing
Utilization
Vaccination
Vaccines
Vaxarray Coronavirus (CoV) seroassay
Viral diseases
Young Adult
title A statistically established reference value determined for the Vaxarray Coronavirus (CoV) seroassay to characterize vaccination and natural infection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T10%3A25%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20statistically%20established%20reference%20value%20determined%20for%20the%20Vaxarray%20Coronavirus%20(CoV)%20seroassay%20to%20characterize%20vaccination%20and%20natural%20infection&rft.jtitle=BMC%20infectious%20diseases&rft.au=Porras,%20Francisco%20Mimica&rft.date=2024-11-15&rft.volume=24&rft.issue=1&rft.spage=1308&rft.epage=11&rft.pages=1308-11&rft.artnum=1308&rft.issn=1471-2334&rft.eissn=1471-2334&rft_id=info:doi/10.1186/s12879-024-10117-5&rft_dat=%3Cgale_doaj_%3EA816301800%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c457t-df80dc96955f09519b74beaf65021f66ab2ee90f7b1ed44f1b438ce8569e92713%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3142292469&rft_id=info:pmid/39548371&rft_galeid=A816301800&rfr_iscdi=true